Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer

Autor: Secord, Angeles Alvarez, McCollum, Michael, Davidson, Brittany A., Broadwater, Gloria, Squatrito, Robert, Havrilesky, Laura J., Gabel, Anne C., Starr, Mark D., Brady, J. Chris, Nixon, Andrew B., Duska, Linda R.
Zdroj: In Gynecologic Oncology June 2019 153(3):555-561
Databáze: ScienceDirect